Total Payments
$4,329
2024 Payments
$1,526
Companies
29
Transactions
283
Medicare Patients
1,259
Medicare Billing
$66,939
Payment Breakdown by Category
Food & Beverage$4,329 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,329 | 283 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $766.14 | 54 | $0 (2024) |
| Lilly USA, LLC | $764.96 | 58 | $0 (2024) |
| Dexcom, Inc. | $461.15 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $383.20 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $328.92 | 20 | $0 (2024) |
| ABBVIE INC. | $276.80 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $185.86 | 11 | $0 (2024) |
| PFIZER INC. | $156.19 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $142.17 | 10 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $110.42 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,526 | 93 | AstraZeneca Pharmaceuticals LP ($247.11) |
| 2023 | $1,375 | 93 | Lilly USA, LLC ($336.56) |
| 2022 | $1,141 | 76 | Lilly USA, LLC ($237.51) |
| 2021 | $287.32 | 21 | DEXCOM, INC. ($106.64) |
All Payment Transactions
283 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Oncology | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $8.71 | General |
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Obesity | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 730 | 1,004 | $114,790 | $39,049 |
| 2022 | 13 | 529 | 623 | $75,494 | $27,890 |
Total Patients
1,259
Total Services
1,627
Medicare Billing
$66,939
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 248 | $49,352 | $15,746 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 184 | $23,368 | $7,814 | 33.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $18,265 | $6,587 | 36.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 22 | 22 | $9,284 | $2,860 | 30.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 171 | 236 | $2,124 | $1,982 | 93.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 23 | $1,665 | $1,626 | 97.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,627 | $835.52 | 14.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 23 | $733.00 | $655.42 | 89.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 15 | 16 | $3,030 | $648.80 | 21.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 22 | $682.00 | $175.40 | 25.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 39 | 52 | $468.00 | $110.90 | 23.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 96 | $192.00 | $7.70 | 4.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 129 | 165 | $20,955 | $8,752 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 123 | $24,477 | $8,459 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $10,397 | $3,880 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $7,944 | $2,191 | 27.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 21 | $1,239 | $1,214 | 98.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 23 | 23 | $2,990 | $933.91 | 31.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $3,728 | $793.15 | 21.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 23 | $667.00 | $629.28 | 94.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 90 | 116 | $1,044 | $339.74 | 32.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 17 | 17 | $697.00 | $275.74 | 39.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 11 | 13 | $533.00 | $210.76 | 39.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 19 | $589.00 | $154.12 | 26.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 24 | 26 | $234.00 | $57.46 | 24.6% |
About Amber Freeman
Amber Freeman is a Family healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/25/2020. The National Provider Identifier (NPI) number assigned to this provider is 1780218123.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amber Freeman has received a total of $4,329 in payments from pharmaceutical and medical device companies, with $1,526 received in 2024. These payments were reported across 283 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,329).
As a Medicare-enrolled provider, Freeman has provided services to 1,259 Medicare beneficiaries, totaling 1,627 services with total Medicare billing of $66,939. Data is available for 2 years (2022–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Dothan, AL
- Active Since 02/25/2020
- Last Updated 08/22/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1780218123
Products in Payments
- Dexcom G6 Transmitter (Medical Supply) $354.51
- MOUNJARO (Drug) $345.47
- Rybelsus (Drug) $308.61
- FARXIGA (Drug) $291.95
- Ozempic (Drug) $269.37
- TRELEGY ELLIPTA (Drug) $256.68
- TRULICITY (Drug) $239.06
- JARDIANCE (Drug) $193.34
- NURTEC ODT (Drug) $179.19
- Wegovy (Drug) $167.63
- UBRELVY (Drug) $113.38
- XIFAXAN (Drug) $110.42
- DEXCOM G6 TRANSMITTER (Device) $106.64
- BELSOMRA (Drug) $101.96
- Vascepa (Drug) $96.78
- VRAYLAR (Drug) $93.26
- AIRSUPRA (Drug) $91.25
- TRADJENTA (Drug) $82.53
- ELIQUIS (Drug) $66.11
- ZEPBOUND (Drug) $66.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Dothan
Keesha Tyler, Fnp, FNP
Family — Payments: $8,865
Family $8,865
Megan Tillman, Crnp, CRNP
Family — Payments: $8,837
Family $8,837
Jenna Oates, Arnp, ARNP
Family — Payments: $8,137
Family $8,137
Kelli Anderson, Crnp, CRNP
Family — Payments: $7,993
Family $7,993
Tina Cochran
Family — Payments: $7,896
Family $7,896
Ms. Alexis Wood, C.r.n.p, C.R.N.P
Family — Payments: $7,668
Family $7,668